Comment on: "Donor demographics and leukopak consistency: Yield and composition as operational benchmarks for cell-therapy starting materials" by Gómez-Gràcia et al. Curr Res Transl Med 2026;74:103591

Current Research in Translational Medicine · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles